The ecosystem surrounding the pharmaceutical industry has become intertwined and complex, leading to noncompliance. Learn a path forward to bring transparency and integrity to these critical programs.

Eyebrow text


In 2019, total drug discounts reached $175 billion. According to our estimates, at least 5% are noncompliant… adding up to nearly $9 billion in lost revenue for manufacturers in 2019 alone.
Kalderos platform solutions enable manufacturers to identify and prevent noncompliance, ensuring the right discount to the right party on the right transaction®.

The 340B Drug Pricing Program is a lifeline for millions of patients and the providers that serve them—but rapid growth, increasing complexity, and limited data visibility are putting the program at risk.
As the program expands and overlaps with Medicaid, commercial contracts, and upcoming regulations like the Inflation Reduction Act’s Max Fair Price, compliance challenges and inefficiencies are growing.
This whitepaper explores the critical challenges facing manufacturers and covered entities, and why claims-level data is the key to protecting program integrity and improving outcomes.
Inside, you’ll learn:
Download the whitepaper to uncover actionable insights and a data-driven path to 340B reform that strengthens compliance, improves efficiency, and ensures that the patients who rely on 340B continue to get the care they need.
We’ll show you how Kalderos 340B Pay facilitates easy exchange and validation of claims level data for 340B contract pharmacy dispenses, enabling holistic visibility across discount programs to identify more noncompliance.
You’ll see firsthand how greater clarity around 340B contract pharmacy dispenses enables you to ensure the discount is paid promptly to the healthcare provider, and respond with confidence to duplicate MDRP or commercial rebate claims.
Every drug manufacturer has unique needs. A member of our team will work with you one-on-one to assess how Kalderos’ Drug Discount Management platform can work for you.
By submitting this form, I agree that Kalderos may contact me at the email address or phone number above to tell me about its services.
By submitting this form, I agree that Kalderos.com may contact me at the email address or phone number above to tell me about its services.

By submitting this form, I agree that Kalderos may contact me at the email address or phone number above to tell me about its services.
Get up to speed on 340B: download the eBook, "What you need to know: The 340B Drug Pricing Program."
By submitting this form, I agree that Kalderos may contact me at the email address or phone number above to tell me about its services.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris commodo euismod eros eget finibus. Ut vestibulum ex sed condimentum dictum. Cras purus massa, volutpat at nunc sed, commodo vestibulum tellus.
Kalderos helps manufacturers:
Utilize our interactive interface to manage your drug discount programs and track claims to ensure the right discount to the right party on the right transaction.
Only Kalderos has a multi-sided tech-enabled platform that connects manufacturers, providers and states, allowing all to benefit from shared data transparency.
Only Kalderos has a multi-sided tech-enabled platform that connects manufacturers, providers and states, allowing all to benefit from shared data transparency.
In 2019, total drug discounts reached $175 billion. According to our estimates, at least 5% are noncompliant… adding up to nearly $9 billion in lost revenue for manufacturers in 2019 alone.
Kalderos platform solutions enable manufacturers to identify and prevent noncompliance, ensuring the right discount to the right party on the right transaction®.
tools built on our platform
tools built on our platform
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Fusce viverra ipsum quis pellentesque malesuada.
We have a wide range of helpful resources for you.
Visit Kalderos’ help center for assistance with your Kalderos account.